| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Parrot David is a Chief Financial Officer at Scribe Therapeutics Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $32K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | SCTX Scribe Therapeutics Inc. | Chief Financial Officer | Buy | 2,666 | $15.00 | $39,990.00 | New |